acridines has been researched along with Lassitude in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caponigro, F; Coudert, B; Dittrich, C; Fumoleau, P; Gamucci, T; Hermans, C; Lacombe, D; Paoletti, X; Paz-Ares, L; Salzberg, M | 1 |
| Petrilowitsch, N; Spiegelberg, U | 1 |
1 trial(s) available for acridines and Lassitude
| Article | Year |
|---|---|
Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer.
Topics: Acridines; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Enzyme Inhibitors; Epilepsy; Fatigue; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Venous Thrombosis | 2003 |
1 other study(ies) available for acridines and Lassitude
| Article | Year |
|---|---|
[Dimetacrin- a new tricyclic antidepressive agent. Public informative studies in the clinical and policlinical centers].
Topics: Acridines; Adult; Aged; Antidepressive Agents; Chronic Disease; Dysautonomia, Familial; Fatigue; Female; Headache; Humans; Male; Methylamines; Middle Aged; Nausea; Sleep Wake Disorders; Sweating | 1970 |